Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (606,044)	$ (5,090,321)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based cost on issuance of warrants		2,874,895
Amortization of debt discount and deferred financing costs	166,434	176,659
Amortization of intangible assets		12,841
Stock-based compensation		297,360
Change in fair value of derivative	19,896	190,841
Loss on debt conversion		257,810
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	19,444	(1,904)
Accounts payable and accrued expenses	134,590	364,500
Accounts payable to related party	14,663	(45,349)
Net cash used in operating activities	(251,017)	(962,668)
Cash flows from financing activities:
Proceeds from sales of common stock		51,805
Proceeds from convertible debt related to joint venture		500,000
Proceeds from short-term loan, other	200,000
Repaid of short-term loans, others		(60,000)
Net cash provided by financing activities	200,000	491,805
Net increase (decrease) in cash	(51,017)	(470,863)
Cash - beginning of period	261,452	588,769	$ 588,769
Cash - end of period	210,435	117,906	$ 261,452
Supplemental cash flow information:
Interest paid	99,814	100,882
Income taxes paid
Non cash investing and financing activities:
Common shares issued upon partial conversion of debt	$ 71,749	$ 721,064